“…An FS product, TISSEEL/TISSUCOL (Baxter Healthcare Corp, Deerfield, IL, USA), manufactured with a 500 IU/ml thrombin concentration, has been used as an alternative fixation method in multiple laparoscopic transabdominal preperitoneal (TAPP) and totally entraperitoneal (TEP) series [5,[8][9][10][11][12][13]. Another formulation of FS, ARTISS (Baxter Healthcare Corp), contains a lower concentration of thrombin and received Food and Drug Administration (FDA) approval in 2008 for the purpose of skin graft fixation to burn wound beds [14].…”